Protocol No. Ptcemf-gd-004, entitled A multicenter randomized placebo-controlledPhase III study on the safety and efficacy of deflazacort (emflaza) In patients withLimb-girdle muscular dystrophy 2i (lgmd2i)

Project: Research project

Project Details

Description

Protocol No. Ptcemf-gd-004, entitled A multicenter randomized placebo-controlled Phase III study on the safety and efficacy of deflazacort (emflaza) In patients with Limb-girdle muscular dystrophy 2i (lgmd2i)
StatusActive
Effective start/end date3/8/199/30/24

Funding

  • PTC Therapeutics, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.